Sign in

Pilar Domingo-Calap

@pilardomingoc.bsky.social
272 followers 173 following 29 posts

PI Environmental and Biomedical Virology Lab #EnBiVirLab Universitat de Valencia-CSIC @VLCphagehunters Co-founder and CSO at Evolving Therapeutics @evolving_spain Spain

PostsRepliesMedia
Reposted by Pilar Domingo-Calap
Maria Dzunkova @dzunkovam.bsky.social · 06/06/2026
Yesterday I was in the #PhD viva tribunal of Lucas Mora. Excellent thesis supervised by Pilar Domingo-Calap @pilardomingoc.bsky.social and Rafael Sanjuan @rafa-sanjuan.bsky.social from @i2sysbio.es about #phages of Klebsiella I got a very nice present - these phage and bacteria coasters #microsky
141
Reposted by Pilar Domingo-Calap
Celia Ferriol-González @celiaferriolg.bsky.social · 03/06/2026
On Monday June 1, I finally defended my PhD thesis entitled "Genetic determinants and implications of host range in Klebsiella phages". Thank you to my supervisor @pilardomingoc.bsky.social, and my team for these years filled with a lot of learning and great moments.
291
Reposted by Pilar Domingo-Calap
Antimicrobianos Hub CSIC @amrhubcsic.bsky.social · 16/02/2026
🔬 Empieza tu camino científico con las #JAEIntro ICU en Conexión Resistencia Antimicrobianos (AMR) del @CSIC. 6 meses, 20h/semana, 600€/mes. Para estudiantes de grado o máster con ganas de investigar. 👉 www.conexion-amr.csic.es/empieza-tu-c...
033
Reposted by Pilar Domingo-Calap
Facultat de Ciències Biològiques de la Universitat de València @biologiques-uv.bsky.social · 10/12/2025
🗞️Un estudi liderat per @pilardomingoc.bsky.social , professora de la Facultat, i @celiaferriolg.bsky.social , doctoranda en Biodiversitat i Biologia Evolutiva, revela com certs virus evolucionen i s’adapten per a infectar nous bacteris. 🔗Més informació:
ir.uv.es
Un estudi liderat per una professora de la Facultat revela com certs virus evolucionen i s’adapten per a infectar nous bacteris
Un estudi liderat per Pilar Domingo-Calap, professora del departament de Genètica de la Facultat de Ciències Biològiques i la doctoranda en Biodiversitat i Biologia Evolutiva, Celia Ferriol-González, les dos investigadores de l’Institut de Biologia...
012
Reposted by Pilar Domingo-Calap
Maria Dzunkova @dzunkovam.bsky.social · 06/12/2025
My @i2sysbio.es colleagues Lucas Mora, Rafael Sanjuan @rafa-sanjuan.bsky.social and Pilar Domingo Calap @pilardomingoc.bsky.social published a paper about reversible phenotypic resistance to phages in Klebsiella. 👏👏 Congratulations! 🧬🖥🧪🦠🧫 #microsky #viruses #phages www.cell.com/iscience/ful...
cell.com
Reversible phenotypic resistance to phage infection via capsule downregulation in Klebsiella pneumoniae
Molecular biology; Microbiology; Cell biology
0154
Reposted by Pilar Domingo-Calap
Maria Dzunkova @dzunkovam.bsky.social · 05/12/2025
My @i2sysbio.es colleague Pilar Domingo-Calap @pilardomingoc.bsky.social speaking at the Pangenome congress in Valencia 🇪🇸 about the success of the personalized #phage therapy achieved by her company Evolving Therapeutics and phage experimental evolution done in her lab 👏👏👏 #microsky #viruses 🧬🖥🧪🦠🧫
082
Reposted by Pilar Domingo-Calap
PLOS Biology @plosbiology.org · 28/11/2025
Capsule diversity limits #phage host range by affecting receptor-binding protein (RBP) interactions in capsulated #bacteria. @pilardomingoc.bsky.social &co show that generalist phages evolve host range via RBP mutation & recombination, but specialists remain stable @plosbiology.org 🧪 plos.io/48nvOqY
Graphic representation of the recombination events in the Sugarlandvirus I and J variants. Top left: Representation of the variants isolates in the different strains in the three lines. Genome fragments of each parent are represented in a different color. Regions with the most abundant recombination events are marked and associated with a schematic representation of the functional annotation and intergenomic similarity between the two parental phages. Bottom left: 3D folding of the RBPγ. The consensus recombinant region, which is associated with the infection of the K-type 47, is represented in light orange. Variable positions detected in the protein sequence alignment of the variants are represented as hot pink spheres. The table indicates the percentage of identity of the parental protein sequences in three protein regions limited by the amino acids indicated. Right: Transmission electron microscopy (TEM) image of Klebsiella myoviruses artificially coloured, showing their characteristic contractile tails and icosahedral capsids. Image acquired by the Environmental and Biomedical Virology group (Institute for Integrative Systems Biology, Universitat de València-CSIC).
1127
Reposted by Pilar Domingo-Calap
PLOS Biology @plosbiology.org · 28/11/2025
Capsule diversity limits #phage host range by affecting receptor-binding protein (RBP) interactions in capsulated #bacteria. @pilardomingoc.bsky.social &co show that generalist phages evolve host range via RBP mutation & recombination, but specialists remain stable @plosbiology.org 🧪 plos.io/48nvOqY
Graphic representation of the recombination events in the Sugarlandvirus I and J variants. Top left: Representation of the variants isolates in the different strains in the three lines. Genome fragments of each parent are represented in a different color. Regions with the most abundant recombination events are marked and associated with a schematic representation of the functional annotation and intergenomic similarity between the two parental phages. Bottom left: 3D folding of the RBPγ. The consensus recombinant region, which is associated with the infection of the K-type 47, is represented in light orange. Variable positions detected in the protein sequence alignment of the variants are represented as hot pink spheres. The table indicates the percentage of identity of the parental protein sequences in three protein regions limited by the amino acids indicated. Right: Transmission electron microscopy (TEM) image of Klebsiella myoviruses artificially coloured, showing their characteristic contractile tails and icosahedral capsids. Image acquired by the Environmental and Biomedical Virology group (Institute for Integrative Systems Biology, Universitat de València-CSIC).
1156
Pilar Domingo-Calap @pilardomingoc.bsky.social · 28/11/2025
Very proud of @celiaferriolg.bsky.social! Amazing experimental evolution for phage optimization and for host range expansion, allowing us to understand the evolvability of phage RBPs. This work is part of her PhD project at the #EnBivirLab @i2sysbio.es @uv.es @ccbiologiquesuv.bsky.social
076
Reposted by Pilar Domingo-Calap
PLOS Biology @plosbiology.org · 28/11/2025
Capsule diversity limits #phage host range by affecting receptor-binding protein (RBP) interactions in capsulated #bacteria. @pilardomingoc.bsky.social &co show that generalist phages evolve host range via RBP mutation & recombination, but specialists remain stable @plosbiology.org 🧪 plos.io/48nvOqY
Graphic representation of the recombination events in the Sugarlandvirus I and J variants. Top left: Representation of the variants isolates in the different strains in the three lines. Genome fragments of each parent are represented in a different color. Regions with the most abundant recombination events are marked and associated with a schematic representation of the functional annotation and intergenomic similarity between the two parental phages. Bottom left: 3D folding of the RBPγ. The consensus recombinant region, which is associated with the infection of the K-type 47, is represented in light orange. Variable positions detected in the protein sequence alignment of the variants are represented as hot pink spheres. The table indicates the percentage of identity of the parental protein sequences in three protein regions limited by the amino acids indicated. Right: Transmission electron microscopy (TEM) image of Klebsiella myoviruses artificially coloured, showing their characteristic contractile tails and icosahedral capsids. Image acquired by the Environmental and Biomedical Virology group (Institute for Integrative Systems Biology, Universitat de València-CSIC).
155
Reposted by Pilar Domingo-Calap
Ákos T Kovács @evolvedbiofilm.bsky.social · 27/11/2025
The host range of generalist and specialist phages in capsule-diverse Klebsiella hosts is driven by the evolvability of receptor-binding proteins @plosbiology.org from @pilardomingoc.bsky.social journals.plos.org/plosbiology/...
journals.plos.org
The host range of generalist and specialist phages in capsule-diverse Klebsiella hosts is driven by the evolvability of receptor-binding proteins
Capsule diversity limits phage host range by affecting RBP interactions in capsulated bacteria. This study shows that generalist phages evolve host range through RBP mutations and recombination, while...
02712
Reposted by Pilar Domingo-Calap
Facultat de Ciències Biològiques de la Universitat de València @biologiques-uv.bsky.social · 24/10/2025
👉 EVOLVING THERAPEUTICS, s'encarrega de la prevenció, diagnòstic i tractament de bacteris patògens resistents a antibiòtics amb una metodologia basada en fags. Cofundada i dirigida per @pilardomingoc.bsky.social , exalumna i professora de la Facultat. ▶️ go.uv.es/Is1CpTJ
youtube.com
Envolving Therapeutics (Spin-off de la Facultat) | VDS 2025
YouTube video by Facultat de Ciències Biològiques
121
Reposted by Pilar Domingo-Calap
Facultat de Ciències Biològiques de la Universitat de València @biologiques-uv.bsky.social · 22/10/2025
Per finalitzar l' Inoovation Stage de #VDS, tots els participants pujen per fer una #taularodona.
011
Reposted by Pilar Domingo-Calap
Facultat de Ciències Biològiques de la Universitat de València @biologiques-uv.bsky.social · 22/10/2025
🌀Envolving Therapeutics, spin-off de @ccbiologiquesuv.bsky.social al #VDS com a empresa del Parc Científic.
121
Reposted by Pilar Domingo-Calap
Facultat de Ciències Biològiques de la Universitat de València @biologiques-uv.bsky.social · 22/10/2025
👩🏼‍🔬 @pilardomingoc.bsky.social , exalumna de @ccbiologiquesuv.bsky.social i actual professora, dóna a conèixer la seu empresa, Envolving Therapeutics, al Innovation Stage de #VDS.
111
Reposted by Pilar Domingo-Calap
I2SysBio @i2sysbio.es · 15/10/2025
🎉👏 #I2SysBio (@uv.es - @csic.es) researchers Rafael Sanjuán, Andrés Moya and @pilardomingoc.bsky.social are included in Stanford University's Word Ranking Scientists. This ranking recognises the top 2% of authors worldwide for the excellence of their intellectual output. www.uv.es/uvweb/biolog...
uv.es
Investigadors de la Facultat de Ciències Biològiques al Stanford University - World Ranking of Scientists dels més influents del món
La setmana passada es va publicar l’ Stanford University - World Ranking of Scientists. Una classificació de més de 236.313 científics que conformen el Top 2% d'autors més citats basada en publicacion...
052
Pilar Domingo-Calap @pilardomingoc.bsky.social · 14/10/2025
Proud to be included in the top 2% World Ranking of Scientist @stanforduniversity.bsky.social, and to be the only woman at my Faculty in 2024 @ccbiologiquesuv.bsky.social. Thanks to my lab #EnBiVirLab @i2sysbio.es @uv.es @csic.es, all collaborators, and special thanks to all #VLCPhageHunters!
3122
Reposted by Pilar Domingo-Calap
Facultat de Ciències Biològiques de la Universitat de València @biologiques-uv.bsky.social · 13/10/2025
📰Investigadors de l'I² SysBio desenrotllen una IA pionera per a predir l'acció dels fags contra bacteris. 🖇️Més informació: links.uv.es/4plKymq
links.uv.es
Investigadors de l'I² SysBio desenrotllen una IA pionera per a predir l'acció dels fags contra bacteris
Un equip de l'Institut de Biologia Integrativa de Sistemes (I²SysBio) —centre mixt de la Universitat de València i el CSIC—, liderat per Robby Concha-Eloko, investigador i doctorant de Biodiversitat i...
011
Reposted by Pilar Domingo-Calap
UCC+i UV @ucciuv.bsky.social · 08/10/2025
#UVCiència @beatrizbeamud.bsky.social @pilardomingoc.bsky.social @rafa-sanjuan.bsky.social @i2sysbio.es @uv.es www.uv.es/uvweb/unitat...
uv.es
Desenvolupen una IA per a llegir el ‘codi’ dels virus bacterians i dissenyar tractaments amb fags personalitzats
Un equip d’investigació de l’Institut de Biologia Integrativa de Sistemes (I²SysBio), centre mixt de la Universitat de València i del Consell Superior d’Investigacions Científiques (CSIC), ha desenvol...
032
Reposted by Pilar Domingo-Calap
I2SysBio @i2sysbio.es · 08/10/2025
👩‍🔬La investigadora del #I2SysBio (@uv.es-@csic.es) @pilardomingoc.bsky.social ha sido propuesta por la revista Magas de @elespanol.com para formar parte del Top 100 Mujeres Líderes. 🔗Te invitamos a leer su propuesta y votarla. 💜¡Enhorabuena, Pilar! www.elespanol.com/mujer/lastop...
elespanol.com
Vota por Pilar Domingo Calap en las Top 100 Mujeres Líderes en España - Votaciones 11 Edición - magasIN
Votaciones para Pilar Domingo Calap en la categoría Académicas e Investigadoras - Top 100 Mujeres Líderes en España 11ª edición
012
Reposted by Pilar Domingo-Calap
Antimicrobianos Hub CSIC @amrhubcsic.bsky.social · 22/09/2025
Una paciente con fibrosis quística e infección crónica causada por P. aeruginosa supera un rechazo agudo de trasplante pulmonar gracias a una terapia basada en la combinación de fagos, inmunosupresores y antibióticos. Estudio liderado por @pilardomingoc.bsky.social elpais.com/ciencia/2025...
elpais.com
Los fagos le salvan la vida a Irene, que recibió y rechazó cuatro pulmones trasplantados
Científicos y médicos se sirven de estos virus que atacan a las bacterias para eliminar una infección resistente a los antibióticos que afectó a una paciente valenciana durante 30 años
044
Reposted by Pilar Domingo-Calap
Maria Dzunkova @dzunkovam.bsky.social · 12/09/2025
A patient with cystic fibrosis overcomes rejection of lung transplant through phage therapy! My colleagues from @i2sysbio.es led by Pilar Domingo Calap @pilardomingoc.bsky.social are saving patients' lives with phages. Truly admirable! 👏 www.i2sysbio.es/communicatio... #microsky #phages #viruses 🧪🦠🧫
i2sysbio.es
A patient with cystic fibrosis overcomes acute rejection of lung transplant through phage therapy
<p><strong>A team led by the Institute for Integrative Systems Biology (I2SysBio, UV-CSIC) has succeeded in eradicating a chronic <em>Pseudomonas aeruginosa</em> infection in a cystic fibrosis (CF) pa...
59623
Reposted by Pilar Domingo-Calap
pepa-anton.bsky.social @pepa-anton.bsky.social · 12/09/2025
Great job by the brilliant @pilardomingoc.bsky.social and her team!
155
Reposted by Pilar Domingo-Calap
Juli Peretó @julipereto.bsky.social · 11/09/2025
A patient with cystic fibrosis overcomes acute rejection of lung transplant through phage therapy www.i2sysbio.es/communicatio... bravo @pilardomingoc.bsky.social 👏
i2sysbio.es
A patient with cystic fibrosis overcomes acute rejection of lung transplant through phage therapy
<p><strong>A team led by the Institute for Integrative Systems Biology (I2SysBio, UV-CSIC) has succeeded in eradicating a chronic <em>Pseudomonas aeruginosa</em> infection in a cystic fibrosis (CF) pa...
181
Reposted by Pilar Domingo-Calap
Revista Mètode @revistametode.bsky.social · 10/09/2025
✍️ Vos deixem per ací l'article sobre els fags que va escriure per a Mètode en el número 112: «Els virus dels bacteris» 🦠
metode.cat
Els virus dels bacteris - Revista Mètode
L'ús dels fags en biomedicina pot abordar la problemàtica de la resistència dels bacteris als antibiòtics. No obstant això, encara hi ha punts febles per a implantar-los en la pràctica clínica.
112
Reposted by Pilar Domingo-Calap
Universitat de València-UV @uv.es · 10/09/2025
#UV | 🔬Una pacient amb fibrosi quística supera amb teràpia de fags el rebuig agut del seu trasplantament pulmonar ℹ️ Més info i accés a l'article complet:
f.mtr.cool
Una pacient amb fibrosi quística supera amb teràpia de fags el rebuig agut del seu trasplantament pulmonar
Un equip liderat per la Universitat de València en l'Institut de Biologia Integrativa de Sistemes (I2SysBio, UV-CSIC) ha aconseguit erradicar la infecció crònica per ‘Pseudomonas aeruginosa’ en una pacient de fibrosi quística (FQ) amb doble...
032
Reposted by Pilar Domingo-Calap
I2SysBio @i2sysbio.es · 10/09/2025
🔬Los fagos salvan vidas @elpais.com publica la historia de cómo un tratamiento experimental de fagoterapia, desarrollado por @pilardomingoc.bsky.social y su equipo en el #I2SysBio (@uv.es- @csic.es), le salvó la vida a Irene, una paciente con fibrosis quística. elpais.com/ciencia/2025...
elpais.com
Los fagos le salvan la vida a Irene, que recibió y rechazó cuatro pulmones trasplantados
Científicos y médicos se sirven de estos virus que atacan a las bacterias para eliminar una infección resistente a los antibióticos que afectó a una paciente valenciana durante 30 años
063
Reposted by Pilar Domingo-Calap
Revista Mètode @revistametode.bsky.social · 10/09/2025
🗞️ Aquesta matinada El País ha publicat aquest article sobre com els fags, virus que es poden utilitzar per combatre bacteris resistents que no tenen tractament, han salvat la vida d'una pacient. I d'això a Mètode ja va parlar la viròloga @pilardomingoc.bsky.social
elpais.com
Los fagos le salvan la vida a Irene, que recibió y rechazó cuatro pulmones trasplantados
Científicos y médicos se sirven de estos virus que atacan a las bacterias para eliminar una infección resistente a los antibióticos que afectó a una paciente valenciana durante 30 años
142
Reposted by Pilar Domingo-Calap
Revista Mètode en español @revistametodeesp.bsky.social · 10/09/2025
🗞️ Esta madrugada El País ha publicado este artículo sobre como los fagos, virus que combaten bacterias, han salvado la vida de una paciente. Y de esto en Mètode ya habló la viróloga @pilardomingoc.bsky.social
elpais.com
Los fagos le salvan la vida a Irene, que recibió y rechazó cuatro pulmones trasplantados
Científicos y médicos se sirven de estos virus que atacan a las bacterias para eliminar una infección resistente a los antibióticos que afectó a una paciente valenciana durante 30 años
122
Reposted by Pilar Domingo-Calap
Ⓙⓐⓥⓘⓔⓡ🇵🇸🍉 Ⓑⓤⓒⓔⓣⓐ🇺🇦🇪🇺 @javierbuceta.bsky.social · 10/09/2025
A ver si lo ve @davidbroncano.bsky.social ...
131
Reposted by Pilar Domingo-Calap
Ⓙⓐⓥⓘⓔⓡ🇵🇸🍉 Ⓑⓤⓒⓔⓣⓐ🇺🇦🇪🇺 @javierbuceta.bsky.social · 10/09/2025
Algunos en el @i2sysbio.es hacemos "cosas" y luego hay gente como @pilardomingoc.bsky.social que hace esto 👇 Brava! 👩‍🔬😍🧫♀️🧪 elpais.com/ciencia/2025...
elpais.com
Los fagos salvaron la vida a Irene, que recibió y rechazó cuatro pulmones trasplantados
Científicos y médicos se sirven de estos virus que atacan a las bacterias para eliminar una infección resistente a los antibióticos que afectó a una paciente valenciana durante 30 años
1115
Reposted by Pilar Domingo-Calap
Maria Dzunkova @dzunkovam.bsky.social · 26/08/2025
Congratulations to our multidisciplinary team: @i2sysbio.es 🇪🇸: Vicente Arnau @vicentarnau.bsky.social, Alicia Ortiz-Maiques, Juan Valero-Tebar, Lucas Mora-Quilis, Pilar Domingo-Calap @pilardomingoc.bsky.social @atrandi.bsky.social 🇱🇹: Vaida Kurmauskaite, Lorea Campos Dopazo #womeninSTEM #microsky
143
Reposted by Pilar Domingo-Calap
Maria Dzunkova @dzunkovam.bsky.social · 30/07/2025
🚨 Abstract submission is open for Pangenome2025 in Valencia! #microsky #bioinformatics 🧪🦠🧬🖥️ I’m one of the invited speakers. Looking forward to the talks by my @i2sysbio.es colleague Pilar Domingo-Calap @pilardomingoc.bsky.social, and many other great researchers. www.alocongress.com/pangenome2025 🧵
alocongress.com
PANGENOME2025
The biology of prokaryotic cells is directly dependent on the differential gene pools that characterize each cell or strain. This has been a fundamental aspect of epidemiology for delimiting outbreaks...
194
Reposted by Pilar Domingo-Calap
Steph D'Agostino @stephdagostino.bsky.social · 29/07/2025
🫁New in #ASMCaseReports 🫁 Marco Pardo-Freire et al. present a case where phage therapy was used to resolve acute rejection in a bilateral double-lung transplanted patient with cystic fibrosis. @csic.es @pilardomingoc.bsky.social @asm.org Explore the case: doi.org/10.1128/asmc...
122
Pilar Domingo-Calap @pilardomingoc.bsky.social · 28/07/2025
Planazo de domingo! Leyendo Los Buenos Virus en la playa!! Gracias JAL @jalguerrero.bsky.social por dar a conocer el lado bueno de los virus, incluyendo nuestras investigaciones en fagos en la lucha contra bacterias resistentes @i2sysbio.es #EnBiVirLab #VLCphagehunters #EVOLVINGTHERAPEUTICS
021
Reposted by Pilar Domingo-Calap
I2SysBio @i2sysbio.es · 25/07/2025
🧪📽️ La investigadora @pilardomingoc.bsky.social presenta su grupo de investigación Virología Ambiental y Biomédica. Esta entrevista forma parte de una serie de vídeos que ha lanzado el #I2SysBio (@csic.es - @uv.es) sobre los diferentes grupos del centro. #virology www.youtube.com/watch?v=vOgg...
youtube.com
Interview of Pilar Domingo-Calap, PI of the Environmental and Biomedical Virology group
YouTube video by Institute for Integrative Systems Biology I2SysBio
052
Reposted by Pilar Domingo-Calap
quieroserabuela.bsky.social @quieroserabuela.bsky.social · 13/07/2025
En tiempos de infecciones con bacterias multiresistentes a antibióticos, esto es un notición buenísimo.
011
Reposted by Pilar Domingo-Calap
Maria Dzunkova @dzunkovam.bsky.social · 12/07/2025
My colleague Pilar Domingo-Calap @pilardomingoc.bsky.social successfully treated a patient with prosthetic joint infection by her phage therapy 👏👏🏆🦠🧪🧫 #microsky #viruses #phages @uv.es @csic.es @ucciuv.bsky.social
0203
Reposted by Pilar Domingo-Calap
I2SysBio @i2sysbio.es · 11/07/2025
Our researcher Pilar Domingo-Calap @pilardomingoc.bsky.social successfully treated a patient with prosthetic joint infection by her phage therapy 👏👏🏆🦠🧪🧫 #microsky #viruses #phages @uv.es @csic.es @ucciuv.bsky.social
041
Pilar Domingo-Calap @pilardomingoc.bsky.social · 11/07/2025
Phage therapy in a patient with prosthetic join infection in Spain! Another sucessful treatment from the #EnBiVir #VLCphagehunters @i2sysbio.es and #EvolvingTherapeutics in collaboration with Dr. de la Villa #GregorioMarañon @uv.es @csic.es www.sciencedirect.com/science/arti...
sciencedirect.com
Successful phage therapy in a patient with prosthetic joint infection
1153
Reposted by Pilar Domingo-Calap
Ismael Mingarro @ismaelmingarro.bsky.social · 11/07/2025
Now time for @pilardomingoc.bsky.social presenting #EvolvingTherapeutics By the way, just appointed #AssociateProfessor at the @ccbiologiquesuv.bsky.social @uv.es Congrats Pilar!!! 👏🏻👏🏻👏🏻
111
Reposted by Pilar Domingo-Calap
Centro Nacional de Biotecnología (CNB) @cnb-csic.bsky.social · 20/05/2025
Inspiradora jornada 'Career Opportunities in Science: Creating a Start-up', organizada por nuestra Comisión Posdoctoral en el #CNB_CSIC, con @pilardomingoc.bsky.social (Evolving Therapeutics) y José M. Ripalda (Future Voltaics) compartiendo sus experiencias emprendiendo en #ciencia.
051
Pilar Domingo-Calap @pilardomingoc.bsky.social · 31/05/2025
Our first collaboration with @josepsardanyes.bsky.social, first of many more! Great job Marcos and Irene.
011
Reposted by Pilar Domingo-Calap
I2SysBio @i2sysbio.es · 31/05/2025
Marcos Rodríguez, Irene Cantallops, Pilar Domingo-Calap @pilardomingoc.bsky.social & Josep Sardanyés @josepsardanyes.bsky.social from I2SysBio published a paper about quantifying dynamics of #Klebsiella and its #phages, focused on phage-resistant mutants 🦠🧪 #microsky @csic.es @ucciuv.bsky.social
053
Reposted by Pilar Domingo-Calap
I2SysBio @i2sysbio.es · 14/05/2025
🧪 🦠 #pintofscience #womeninSTEM Tres investigadoras del I2SysBio participarán este año en Pint of Science! Este evento internacional de divulgación científica tendrá lugar del 19 al 21 de mayo de 2025. 🌐 pintofscience.es/events/valen... ¿Dónde y cuándo podrás ver sus charlas?⬇️
132
Reposted by Pilar Domingo-Calap
I2SysBio @i2sysbio.es · 14/05/2025
🧪Cecilia Picazo @cecipicam.bsky.social hablará sobre las levaduras 🗓️ 20.5., Max Max. 🧪Pilar Domingo-Calap @pilardomingoc.bsky.social hablará sobre los bacteriófagos 🗓️ 21.5., George Best Rock Club. 🧪Maria Dzunkova @dzunkovam.bsky.social hablará sobre la materia oscura microbiana 🗓️ 21.5., Max Max.
022
Reposted by Pilar Domingo-Calap
Centro Nacional de Biotecnología (CNB) @cnb-csic.bsky.social · 09/05/2025
On 20th May, join us at the CNB for Career Opportunities in Science: Creating a Start-up, organized by our Postdoc Commission, with talks by Dr. @pilardomingoc.bsky.social (Evolving Therapeutics) & Dr. José M. Ripalda (Future Voltaics).
022
Reposted by Pilar Domingo-Calap
Jose A Escudero @jaescudero.bsky.social · 08/05/2025
🧪 Finally out after peer review, our work showing that "Mobile #Integrons carry Phage Defense Systems" is now published in Science 🎉 Short 🧵 www.science.org/doi/10.1126/...
science.org
Mobile integrons encode phage defense systems
Integrons are bacterial genetic elements that capture, stockpile, and modulate the expression of genes encoded in integron cassettes. Mobile integrons (MIs) are borne on plasmids, acting as a vehicle ...
1513680
Pilar Domingo-Calap @pilardomingoc.bsky.social · 11/04/2025
Muchas gracias!!! Ojalá que al menos nos permitan su uso compasivo a mayor escala y poder ayudar a más personas!
120
Reposted by Pilar Domingo-Calap
Tominaga K. (tomiken) @pacyc184.bsky.social · 08/04/2025
Mobile Integrons Encode Phage Defense Systems | bioRxiv www.biorxiv.org/content/10.1101/202…
biorxiv.org
Mobile Integrons Encode Phage Defense Systems
Integrons are bacterial genetic elements that capture, stockpile and modulate the expression of genes encoded in integron cassettes. Mobile Integrons (MI) are borne on plasmids, acting as a vehicle for hundreds of antimicrobial resistance genes among key pathogens. These elements also carry gene cassettes of unknown function ( gcu s) whose role and adaptive value remains unexplored. Here we show that gcu s encode phage resistance systems, many of which are novel. Bacteriophage resistance integron cassettes (BRiCs) can be combined and mixed with resistance cassettes to produce multiphage or drug/phage-resistance. The fitness costs of BRiCs are variable, dependent on the genetic context, and can be modulated by changing the order of cassettes in the array. Hence, MIs act as highly mobile, low-cost defense islands. ![Summary Figure][1]</img> Summary Figure Novel phage defense systems identified in Mobile Integrons. We confronted genes of unknown function from mobile integrons against a panel of phage. We characterized 13 Bacteriophage Resistance integron Cassettes (BRiCs) and confirmed their function in Klebsiella pneumoniae and Pseudomonas aeruginosa . Combined with other cassettes, BRiCs produce multi-phage/antibiotic resistance. Additionally, their cost can be reduced in an array. ### Competing Interest Statement The authors have declared no competing interest. [1]: pending:yes
062